Barium elicits reversal of low-concentration etorphine-induced decrease of potassium conductance in cultures of dissociated dorsal root ganglion neurons

Brain Research

Volumn 754, Issue 1-2, 1997, Pages 303-306

  Fan, Shih Fang ^a,b   Crain, Stanley M ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

Ba2+ modulation of etorphine effect; Ca2+ current; dorsal root ganglion neuron; dual opioid regulation of K2+ conductance; inward K+ conductance; patch clamp whole cell recording

Indexed keywords

BARIUM; ETORPHINE; POTASSIUM CHANNEL;

ANIMAL CELL; ARTICLE; CALCIUM CURRENT; CELL CULTURE; CONTROLLED STUDY; ELECTROPHYSIOLOGY; FETUS; MOUSE; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; SPINAL GANGLION;

ANIMALS; BARIUM; CALCIUM CHANNELS; CELLS, CULTURED; ETORPHINE; FETUS; GANGLIA, SPINAL; KINETICS; MICE; NEURONS; POTASSIUM; POTASSIUM CHANNELS;

EID: 0030889301     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)00074-7     Document Type: Article

References (25)

1. Blane, G.F., Boura, A.L.A., Fitzgerald, A.E. and Lister, R.E., Action of etorphine hydrochloride (M99): a potent morphine-like agent, Br. J. Pharmacol. Chemother., 30 (1967) 11-22.
2. 32P]GTP labeling of multiple G protein alpha subunits, J. Neurochem., 64 (1995) 2534-2543.
3. Chen, G.G., Chalazonitis, A., Shen, K.F. and Grain, S.M., Inhibitor of cyclic AMP-dependent protein kinase blocks opioid-induced prolongation of the action potential of mouse sensory ganglion neurons in dissociated cell cultures, Brain Res., 462 (1988) 372-377.
4. Crain, S.M. and Shen, K.F., Opioids can evoke direct receptor-mediated excitatory effects on sensory neurons, Trends Pharmacol. Sci., 11 (1990) 77-81.
5. Crain, S.M. and Shen, K.F., Etorphine elicits unique inhibitory-agonist and excitatory-antagonist actions at opioid receptors on sensory neurons: new rationale for improved clinical analgesia and treatment of opiate addiction. In: R.S.S. Repaka and H. Sorer (Eds.), Discovery of Novel Opioid Medications, NIDA Monograph No. 147, US Government Printing Office, Washington, DC, 1995, pp. 234-268.
6. Curran, T. and Morgan, J.I., Barium modulates c-fos expression and post-translational modification, Proc. Natl. Acad. Sci. (USA), 83 (1986) 8521-8524.
7. Dickenson, A.H., Sullivan, A.F. and McQuay, H.J., Intrathecal etorphine, fentanyl and buprenorphine on spinal nociceptive neurons in the rat, Pain, 42 (1990) 227-234.
8. K decreases in cultured sensory neurons, Soc. Neurosci. Abstr., 20 (1994) 750.
9. + conductance of DRG neurons and neuroblastoma×DRG neuron hybrid F11 cells, Brain Res., 696 (1995) 97-105.
10. + channels in sensory ganglion neurons, Brain Res., 558 (1991) 166-170.
11. Fields, A., Gafni, M., Oron, Y. and Sarne, Y., Multiple effects of opiates on intracellular calcium level and on calcium uptake in three neuronal cell lines, Brain Res., 687 (1995) 94-102.
12. Hamill, O.P., Marty, A., Nehr, E., Sakmann, B. and Sigworth, F.J., Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches, Pflügers Arch., 391 (1981) 85-100.
13. Hammond, D.L., Presley, R., Gogas, K.R. and Basbaum, A.I., Morphine or U-50,488 suppresses Fos protein-like immunoreactivity in the spinal cord and nucleus tractus solitarii evoked by a noxious visceral stimulus in the rat, J. Comp. Neurol., 315 (1992) 2244-253.
14. + channel, Am. J. Physiol., 268 (1995) C535-C556.
15. Mons, N. and Cooper, D.M.F., Adenylate cyclase: critical foci in neuronal signaling, Trends Neurosci., 18 (1995) 536-542.
16. Peachell, P.T. and Peace, F.L., Divalent cation dependence of the inhibition by phenothiazines of mediators released from mast cells, Br. J. Pharmacol., 97 (1989) 547-555.
17. Shen, K.F. and Grain, S.M., Dual opioid modulation of the action potential duration of mouse dorsal root ganglion neurons in culture, Brain Res., 491 (1989) 227-242.
18. Shen, K.F. and Grain, S.M., Antagonists at excitatory opioid receptors on sensory neurons in culture increase potency and specificity of opiate analgesics and attenuate development of tolerance/dependence, Brain Res., 636 (1994) 286-297.
19. Tolle, T.R., Schadrack, J., Castro-Lopes, J.M., Evan, G., Rogues, B.P. and Zieglgänsberger, W., Effects of Kelatorphan and morphine before and after noxious stimulation on immediate-early gene expression in rat spinal cord neuron, Pain, 56 (1994) 103-112.
20. Uhl, G.R., Childers, S. and Pasternak, G., An opiate-receptor gene family reunion, Trends Neurosci., 17 (1994) 89-93.
21. Van der Kooy, D. and Nagy, J.I., Hyperalgesia mediated by peripheral opiate receptors in the rat, Behav. Brain Res., 17 (1985) 203-211.
22. Wheeler, D.B., Sather, W.A., Randall, A. and Tsien, R.W., Distinctive properties of a neuronal calcium channel and its contribution to excitatory synaptic transmission in the central nervous system. In: L. Stjärne, P. Greengard, S. Grillner, T. Hökfelt and D. Ottoson (Eds.), Molecular and Cellular Mechanisms of Neurotransmitter Release, Raven Press, New York, 1994, pp. 155-171.
23. + currents, J. Neurosci. Res., 42 (1995) 493-503.
24. Wu, G., Lu, Z. and Ledeen, R.W., GM1 conversion of cloned δ-opioid receptor from inhibitor to stimulator of adenylyl cyclase, J. Neurochem., 64 (1995) S104.
25. Xu, J.Y., Fujimoto, J.M. and Tseng, L.F., Involvement of supraspinal ε and μ opioid receptors in inhibition of the tail-flick response induced by etorphine in the mouse, J. Pharmacol. Exp. Ther., 263 (1992) 246-263.